Correlation between Serum RANTES Levels and the Severity of Parkinson’s Disease

Abstract EN

Inflammatory mediators may reflect a role of systemic inflammation in the neurodegenerative process of Parkinson’s disease (PD).

Interleukin-6 (IL-6) and chemokine ligand 5 (CCL5), also known as RANTES (regulated on activation, normal T cell expressed and secreted), have been implicated in neurodegenerative diseases including PD.

Serum levels of RANTES and IL-6 of 78 consecutive PD patients and age-matched 80 controls were measured.

Patients with PD had higher RANTES and IL-6 levels compared with the controls.

We found that serum RANTES levels strongly correlated with Hoehn-Yahr score and disease duration in PD patients.

This study indicated that patients with PD have an on-going systemic inflammatory profile where the elevated peripheral production of RANTES may play a role in the neurodegenerative process.